Research for the reguration of the gene expression of glucose transporters in ischemic heart diseases and its application to gene therapy
Research for the reguration of the gene expression of glucose transporters in ischemic heart diseases and its application to gene therapy
批准号:
10670633
负责人:
HIROE Michiaki
金额:
$2.05万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999
中文摘要
点击翻译按钮获取中文摘要
英文摘要
GLUT1 and GLUT4 are the primary isoforms of glucose transporters expressed in the myocardium. Expression of the GLUT1 gene has been shown to be increased in hypoxic cardiac myocytes. In the present study, we demonstrated hypoxia-mediated induction of GLUT4 gene expression in cultured neonatal rat cardiac myocytes exposed to persistent hypoxia. We also showed that the induction of GLUT1 and GLUT4 mRNAs upon hypoxia was much more abundant in cardiac myocytes than in non-myocytes. The induction of both mRNAs in hypoxic cardiac myocytes was completely abrogated by BAPTA-AM, suggesting the need for an elevated intracellular calcium ion concentration ([Ca^<2+>]_i) in this response. Furthermore, the induction of both mRNAs was attenuated by H7, suggesting the involvement of the protein kinase C (PKC) pathway as well. Nonetheless, our findings in this study suggest that GLUT1 and GLUT4 gene expressions are induced in distinctly different ways. To begin with, the time courses required for the induction of the two genes were different. Secondly, increases in [Ca^<2+>]_i at normoxia with A23187 or veratridine resulted in increases in GLUT1 mRNA but not in GLUT4 mRNA, suggesting that [Ca^<2+>]_i elevation alone is insufficient for the induction of GLUT4 mRNA.Thirdly, H7 only partially inhibited the induction of GLUT1 mRNA, but fully inhibited the induction of GLUT4 mRNA. These results suggest that [Ca^<2+>]_i elevation and PKC activation are both involved in the hypoxic induction of GLUT1 and GLUT4 gene expression, but that the regulatory mechanisms of these genes may differ in this process.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Assessment of Prevalence and Trends of Metabolic Syndrome among Bangladeshi Rural Women : From basic epidemiology to genetic screening
-
批准号:22406025
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.23万
-
财政年份:2010
-
负责人:HIROE Michiaki
-
依托单位:
NOVEL DIAGNOSTIC AND THERAPEUTIC STRATEGY FOR AORTIC ANEURYSM
-
批准号:20390348
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.48万
-
财政年份:2008
-
负责人:HIROE Michiaki
-
依托单位:
APOPTOTIC CELL DEATH OF CARDIOMYOCYTES IN VARIOUS HEART DISEASES
-
批准号:07670765
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.54万
-
财政年份:1995
-
负责人:HIROE Michiaki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
MYO6介导GLUT4膜转运对骨骼肌胰岛素抵
抗的作用及其机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:周春
-
依托单位:
DENND1A通过介导GLUT4转位影响PCOS颗粒细胞糖摄取的作用与机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:窦云德
-
依托单位:
LncRNA YWHAEP1稳定GLUT4蛋白的分子机制及其在促进结直肠癌转移中的作用研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:黎伯胜
-
依托单位:
OSBPL10与OSBPL9作用调控GLUT4转运的机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2022
-
负责人:于海佳
-
依托单位:
IRS1调控GLUT4膜转位介导发育期铅暴露认知功能损伤的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:赵再华
-
依托单位:
厚壳桂属植物中α-吡喃酮类GLUT4转位激动剂的发现及其抗T2DM活性研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:周志望
-
依托单位:
从FGF1—GLUT4轴探讨活血降糖饮调控葡萄糖稳态的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:李茂生
-
依托单位:
维吾尔药黑桑枝作用于GLUT4靶点的抗糖尿病药效物质基础及其作用机制研究
-
批准号:82160796
-
项目类别:地区科学基金项目
-
资助金额:34万元
-
批准年份:2021
-
负责人:庞克坚
-
依托单位:
PKD/MEF2D/Glut4信号通路介导的糖代谢异常在心肌重构中的作用机制研究
-
批准号:82000239
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:耿静
-
依托单位:
ArfGAP3调控GLUT4质膜转运在女性压力性尿失禁发病中的作用机制及相关信号通路
-
批准号:81971364
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:洪莉
-
依托单位: